Stage 3 Mesothelioma Life Expectancy And Treatment Options, Mesothelioma Prognosis Soraya Detlef Blog

Stage 3 mesothelioma treatment options of all the mesothelioma stages stage 3 mesothelioma probably involves the most debate among experts regarding treatment options.

Denise satterley. Stage 3 mesothelioma is a common diagnosis for this type of cancer. About 26 to 38 of stage 3 mesothelioma patients live at least two years after diagnosis. Treatment options at stage 3 are limited the prognosis is poor and life expectancy is short.

A mesothelioma diagnosis at stage 3 has a two year survival rate between 26 and 38. The amount of the affected lymph nodes and response to treatment is what the life expectancy depends on. Approximately 26 30 percent of stage 3 patients live at least 2 years.

Patients may face more limited treatment options as a result. By this stage it has spread into the lymph nodes and other organs near the original site of tumor growth. Mesothelioma life expectancy is an estimate of how long a patient will survive.

Prognosis and life expectancy for stage 3 mesothelioma will vary from patient to patient. The location of the cancer can also influence a patients life expectancy. However at stages 3 and 4 mesothelioma has spread to lymph nodes and distant organs.

Location and tumor type stage and extent of spreading and even overall health tie into the treatment options that will be available to a mesothelioma patient. Stage 3 mesothelioma tumors are usually not resectable surgically removable preventing patients from undergoing the most effective treatment options for increasing their life expectancy. Life expectancy for stages 3 and 4 ranges from 12 16 months.

Stage 3 mesothelioma life expectancy. Tumor removing surgery is still possible but conducted mainly to reduce symptoms. A successful response to surgery and post surgery therapies helps patients live longer.

Patients with peritoneal mesothelioma who receive surgical treatment often have life expectancies greater than 5 years. Patients diagnosed at stages 1 or 2 are usually stronger candidates for a potentially curative treatment than those diagnosed at stages 3 or 4 when treatment options shift to focus on. However even stage 3 patients who cannot receive surgery may benefit from chemotherapy and other treatments.

Patients with stage 3 or 4 pleural mesothelioma have an average life expectancy of up to 16 months. Patients with stage 1 or 2 pleural mesothelioma have an average life expectancy of 19 to 21 months. Stage 3 mesothelioma life expectancy varies based on a number of factors such as a patients health history cell type and cancer type.

Patients tend to live longer if they have a successful surgery and recovery. Stage 3 mesothelioma life expectancy prognosis.